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Background
The mechanistic target of rapamycin (mTOR) is a central
regulator of cell growth and proliferation, and its aberrant
activation is frequent in cancer [1]. We have previously
shown that sterol regulatory element binding protein
(SREBP) is a major transcriptional effector of mTOR
complex 1 (mTORC1) signaling [2]. SREBP is a transcrip-
tion factor that stimulates the expression of genes involved
in the de novo synthesis of lipids [3]. Since mTORC1
is commonly activated in cancer through upstream
oncogenic signaling pathways and enhanced lipogenesis is
a metabolic hallmark of tumor cells, we hypothesize that
the mTORC1-SREBP pathway is important for tumor
metabolism and growth.
Materials and methods
We used a panel of breast cancer cell lines with various
mutations resulting in constitutive mTORC1 activation,
as well as MCF10a cells transformed with oncogenic
KRAS or PIK3CA to explore the role of SREBP in
mTORC1-driven cancers. We used chemical inhibitors
and siRNAs to assess the dependence of our breast
cancer systems on the mTORC1-SREBP pathway for de
novo lipogenesis, proliferation, growth, and cell survival.
Results
Using both the panel of breast cancer cell lines and the
isogenic MCF10a cell lines, we have revealed an essential
role for SREBP in driving lipogenesis and proliferation in
tumor cells. Our results indicate that SREBP and its
lipogenic targets are activated in cell lines with oncogene-
induced mTORC1 signaling, and this activation was
ablated by mTOR inhibitors. mTORC1 signaling promotes
de novo lipogenesis in an SREBP-dependent manner in
cancer cells. In addition, we found that the mTORC1-
stimulated activation of SREBP2 promotes cell growth,
proliferation, and survival of breast cancer cells. We are in
the process of identifying the essential functions of
SREBP2 in breast cancer and assessing the dependence of
breast cancer cells on SREBP2 in vivo. These findings
emphasize the therapeutic potential of targeting lipid
metabolism in cancers, particularly those with activated
mTORC1 signaling.
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